ondansetron has been researched along with Benign Mucosal Pemphigoid in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ocular cicatricial pemphigoid (OCP) is a relatively rare autoimmune disease affecting elderly patients and causing severe symptoms that may culminate in blindness." | 1.40 | Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients. ( Friedman, J; Kleinmann, G; Marcovich, AL; Schattner, A, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Friedman, J | 1 |
| Marcovich, AL | 1 |
| Kleinmann, G | 1 |
| Schattner, A | 1 |
1 other study available for ondansetron and Benign Mucosal Pemphigoid
| Article | Year |
|---|---|
Low-dose pulsed intravenous cyclophosphamide for severe ocular cicatricial pemphigoid in elderly patients.
Topics: Aged; Aged, 80 and over; Antiemetics; Cyclophosphamide; Female; Follow-Up Studies; Humans; Immunosup | 2014 |